Clinical Trial to Evaluate the Safety and Efficacy of JTM201 to Treat Moderate or Severe Glabellar Lines
NCT06246552
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
480
Enrollment
INDUSTRY
Sponsor class
Conditions
Glabellar Lines
Interventions
BIOLOGICAL:
JTM201
BIOLOGICAL:
Placebo
Sponsor
Jetema USA Inc.